Novo Nordisk’s PIONEER PLUS trial has delivered promising A1C and weight loss results for patients with type 2 diabetes taking the oral semaglutide Rybelsus at...

A clinical trial is recruiting participants with type 2 diabetes and chronic kidney disease (CKD) to see how well a combination of glucose-lowering and kidney-protective...

Having diabetes puts you at risk for problems with your kidneys. Learn about the steps you can take, as recommended in the latest ADA Standards of Care, to maintain the...

In the US, it is estimated that 8.5 million people are unaware that they have T2D, which can lead to serious health problems. A new research project addressed this...

Learn more about the PsychoSocial Aspects of Diabetes (PSAD) Study Group and the professionals and people with diabetes making sure we prioritize more than just the...

In case you missed them, below you'll find our top five stories from February 2023. This month's best stories cover various topics including type 2 therapies, the latest...

Medicare will begin covering continuous glucose monitors (CGMs) for a broader group of T2D patients beginning in April.

At diaTribe’s Solvable Problems event in Berlin, we heard from esteemed physicians about their thoughts on the use of technology among people with diabetes.

At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA approved drugs, as well as...

New research from diaTribe and market research firm, dQ&A, is looking to explore how diabetes stigma might be impacting people’s willingness to use insulin pumps and...

Researchers at this week’s 2023 Advanced Technologies and Treatments for Diabetes (ATTD) conference in Berlin provided an update on icodec and efsitora, two new basal...

Leading clinicians at the ATTD conference discussed the need for greater CGM access for people with type 2 diabetes, as well as those with cystic fibrosis-related...

The long-awaited US launch of Dexcom G7 is here! G7 improves on Dexcom’s current continuous glucose monitoring (CGM) system, the G6, with greater accuracy, smaller size...

Fractyl Health, a company that has pioneered a procedure called Duodenal Mucosal Resurfacing, announced on Feb. 8 that it has begun offering its procedure as a type 2...

Access to continuous glucose monitors (CGM) can be severely limited. Tamara Oser, a researcher at the University of Colorado, launched PREPARE 4 CGM, a project to...

New study results showed that using an artificial pancreas, or fully closed-loop automated insulin delivery system, improved time spent in a healthy glucose range by...

The FDA has just announced that Rybelsus has now been approved as an initial treatment option for type 2 diabetes. In addition to the glucose-lowering effects, Rybelsus...

What’s an AGP report, and what does it show? Why does my AGP matter? How can I use an AGP report to improve my blood glucose levels and time in range?

Adults with newly diagnosed type 2 diabetes are at higher risk of having undetected pancreatic cancer. A U.S. clinical trial is recruiting this population to evaluate a...

The FDA recently approved Wegovy (semaglutide), a GLP-1 receptor agonist, as a weight loss treatment for teens ages 12 and up. Wegovy is now the first once-weekly weight...